Filament Health Talks Psilocybin, Psilocin And How Natural Psychedelics Could Conquer The Market

Filament Health FLHLF FH is a clinical-stage psychedelic drug development company creating safe, standardized, naturally-derived psychedelic medicines. 

CEO and Co-Founder Benjamin Lightburn spoke at the Benzinga Psychedelics Capital Conference, April 19, 2022, about the psychedelics industry, the clinical development of psychedelic medicines and how Filament is paving the way with today’s first-ever natural psychedelic drug candidates.

Watch the full video here.

Image via Filament Health

This post contains sponsored advertising content. This content is for informational purposes only and is not intended to be investing advice.

Market News and Data brought to you by Benzinga APIs
Posted In: Penny StocksHealth CareGeneralBenzinga Psychedelics Capital ConferenceFilament HealthPartner Content
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!